Deutsche Bank AG Reaffirms “Hold” Rating for Imperva Inc. (IMPV)
Other equities research analysts also recently issued reports about the stock. Nomura reissued a buy rating and issued a $55.00 price objective (down from $60.00) on shares of Imperva in a research report on Friday, July 15th. BTIG Research reaffirmed a buy rating and issued a $55.00 target price on shares of Imperva in a research report on Monday, July 11th. Needham & Company LLC reaffirmed a hold rating on shares of Imperva in a research report on Tuesday, July 12th. Royal Bank Of Canada dropped their target price on shares of Imperva from $55.00 to $49.00 and set an outperform rating on the stock in a research report on Tuesday, July 12th. Finally, JPMorgan Chase & Co. reaffirmed a hold rating and issued a $46.00 target price on shares of Imperva in a research report on Friday, August 5th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average price target of $52.33.
Imperva (NYSE:IMPV) opened at 49.03 on Friday. Imperva has a 52-week low of $31.11 and a 52-week high of $77.99. The firm’s market capitalization is $1.60 billion. The company’s 50-day moving average is $48.31 and its 200-day moving average is $44.83.
Imperva (NYSE:IMPV) last announced its quarterly earnings data on Thursday, August 4th. The company reported ($0.23) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.04) by $0.19. Imperva had a negative net margin of 23.75% and a negative return on equity of 25.68%. The firm earned $57.87 million during the quarter, compared to analysts’ expectations of $66.06 million. During the same period in the prior year, the company posted ($0.08) earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. On average, analysts predict that Imperva will post ($0.80) EPS for the current year.
In other Imperva news, SVP Mark E. Kraynak sold 2,967 shares of the firm’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $46.15, for a total transaction of $136,927.05. Following the completion of the transaction, the senior vice president now directly owns 2,968 shares in the company, valued at approximately $136,973.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Amichai Shulman sold 937 shares of the firm’s stock in a transaction dated Friday, September 23rd. The shares were sold at an average price of $51.00, for a total transaction of $47,787.00. Following the transaction, the insider now owns 95,084 shares of the company’s stock, valued at $4,849,284. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of IMPV. Tower Research Capital LLC TRC increased its position in Imperva by 2,252.0% in the second quarter. Tower Research Capital LLC TRC now owns 2,352 shares of the company’s stock valued at $101,000 after buying an additional 2,252 shares during the period. Bank of Montreal Can acquired a new position in Imperva during the second quarter valued at $107,000. BlackRock Inc. increased its position in Imperva by 37.1% in the second quarter. BlackRock Inc. now owns 2,596 shares of the company’s stock valued at $111,000 after buying an additional 703 shares during the period. BNP Paribas Arbitrage SA increased its position in Imperva by 63.6% in the third quarter. BNP Paribas Arbitrage SA now owns 3,169 shares of the company’s stock valued at $170,000 after buying an additional 1,232 shares during the period. Finally, Compagnie Lombard Odier SCmA acquired a new position in Imperva during the second quarter valued at $147,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.